Akeega, an oral dual mechanism therapy pairing niraparib with abiraterone, has won a positive committee opinion in Europe for ...
Identification of variants influences treatment decisions. Inhibitors of the poly-ADP-ribose polymerase (PARP) system, a pathway for repairing single-stranded DNA breaks, are recommended for tumors ...
AMPLITUDE is the first clinical trial to evaluate potential therapies for patients with mHSPC and known HRR gene alterations, with positive results supporting the niraparib-based combination regimen a ...
CDK12-Altered Prostate Cancer: Clinical Features and Therapeutic Outcomes to Standard Systemic Therapies, Poly (ADP-Ribose) Polymerase Inhibitors, and PD-1 Inhibitors A total of 109 patients with ...
Dutasteride has long been a staple in the treatment of prostate-related health issues, prized for its efficacy in managing conditions that many face as they age. However, as with many potent ...
Prostate health is a significant concern for many men, particularly as they age. Problems such as frequent urination, discomfort, and declining sexual health can greatly impact quality of life. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results